Cargando…
Additional Information Regarding the SEVITENSION Study
Autor principal: | Ruilope, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147241/ https://www.ncbi.nlm.nih.gov/pubmed/25145548 http://dx.doi.org/10.1007/s12325-014-0144-6 |
Ejemplares similares
-
Regarding the study testing the addition of gemcitabine to concurrent chemoradiotherapy in cervical carcinoma: Clarity needed
por: Revannasiddaiah, Swaroop, et al.
Publicado: (2013) -
Letter regarding “Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab”
por: Bae, Sun Hyun, et al.
Publicado: (2023) -
In Regard to Barker
por: Goff, Peter H., et al.
Publicado: (2021) -
Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring: Some Additional Information
por: Patel, C
Publicado: (2011) -
Does the E gene provide additional information in SARS-CoV-2 PCR?()
por: Zóka, András, et al.
Publicado: (2021)